Co-Authors
This is a "connection" page, showing publications co-authored by TITO R MENDOZA and GARY BRANDON GUNN.
Connection Strength
1.292
-
Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269.
Score: 0.170
-
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80.
Score: 0.154
-
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
Score: 0.152
-
Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module. Balkan Med J. 2016 May; 33(3):339-43.
Score: 0.138
-
Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol. 2015 Oct; 117(1):132-8.
Score: 0.132
-
Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26.
Score: 0.122
-
Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84.
Score: 0.120
-
High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8.
Score: 0.109
-
Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module. Forum Clin Oncol. 2012 Mar; 3(1):29-31.
Score: 0.103
-
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1107-14.
Score: 0.034
-
The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73.
Score: 0.031
-
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9.
Score: 0.028